MRK PEER ANALYSIS

Merck KGaA — metric-by-metric comparison with peers and the industry median

MRKMerck KGaA

🇩🇪 Germany · XETRA · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

MRKIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MRK	ZTS	UTHR	VTRS	NBIX	ELAN	Ind. Median
P/E	24.33	12.19●	20.67	—	27.45	—	21.55
P/B	2.07	9.97	4.51	1.36●	5.39	1.92	1.91
EV/EBITDA	11.70	9.81●	—	12.66	18.25	20.98	12.18
P/S	2.94	3.39	8.39	1.37●	5.92	2.55	2.13

Financial Health
Metric	MRK	ZTS	UTHR	VTRS	NBIX	ELAN	Ind. Median
Current Ratio	1.51	3.15	4.79●	1.60	2.93	2.16	2.22
Debt/Equity	40.5%	285.7%	—	97.9%	11.9%●	61.4%	46.3%
NetDebt/EBITDA	1.38	1.81	—	4.89	-0.95●	4.66	1.24

Profitability
Metric	MRK	ZTS	UTHR	VTRS	NBIX	ELAN	Ind. Median
Net Margin	12.1%	27.8%	40.6%●	-2.0%	21.6%	-4.9%	4.0%
ROE	8.5%	67.0%●	20.3%	-2.0%	22.5%	-3.8%	6.4%
ROA	4.9%	18.1%●	17.8%	-0.8%	15.6%	-1.8%	3.4%
EBITDA Margin	28.5%	42.4%	54.1%●	17.6%	30.8%	15.6%	18.2%

Growth + Dividend
Metric	MRK	ZTS	UTHR	VTRS	NBIX	ELAN	Ind. Median
Rev. Growth	-1.7%	2.4%	5.9%	1.6%	28.6%●	10.5%	7.5%
NI Growth	-10.1%	5.0%	6.3%	—	118.6%●	—	5.0%
Div. Yield	1.5%	2.8%	—	3.0%●	—	—	2.0%
Payout	11.8%	33.6%	—	-188.0%	—	—	0.8%

Valuation
Metric	MRK	BAYN	SHL	FRE	FME	Ind. Median
P/E	24.33	—	18.92	16.57	12.32●	21.55
P/B	2.07	1.73	2.18	1.23	0.88●	1.91
EV/EBITDA	11.70	23.43	12.04	9.49	6.18●	12.18
P/S	2.94	1.10	1.72	1.06	0.60●	2.13

Financial Health
Metric	MRK	BAYN	SHL	FRE	FME	Ind. Median
Current Ratio	1.51●	1.06	1.10	1.27	1.20	2.22
Debt/Equity	40.5%●	134.8%	84.1%	60.2%	83.3%	46.3%
NetDebt/EBITDA	1.38●	9.19	3.04	2.73	2.82	1.24

Profitability
Metric	MRK	BAYN	SHL	FRE	FME	Ind. Median
Net Margin	12.1%●	-4.8%	9.1%	6.4%	4.9%	4.0%
ROE	8.5%	-7.0%	11.4%●	7.5%	6.8%	6.4%
ROA	4.9%●	-2.0%	4.6%	3.4%	2.9%	3.4%
EBITDA Margin	28.5%●	7.7%	19.1%	15.6%	17.9%	18.2%

Growth + Dividend
Metric	MRK	BAYN	SHL	FRE	FME	Ind. Median
Rev. Growth	-1.7%	-2.9%	-0.3%	4.2%●	-0.7%	7.5%
NI Growth	-10.1%	—	0.3%	248.3%●	52.9%	5.0%
Div. Yield	1.5%	0.2%	2.9%	2.5%	3.6%●	2.0%
Payout	11.8%	-5.9%	48.4%	46.3%	44.7%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MRK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.